http://www.streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2024, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Wed, 17 Jul 2024 08:00:00 -0400 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif http://www.streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday http://www.streetinsider.com/Press+Releases/Alltrna+Announces+Updates+to+Its+Board+of+Directors/23472212.html <div class="xn-content"> <ul type="disc"><li><i><person value="APIN:1758666824">Chris Schade</person> appointed as Board Chairperson</i></li><li><i><person>Lynne Parshall</person>, <person>Robert Plenge</person>, M.D., Ph.D., and <person value="APIN:3936886864">Nancy Simonian</person>, M.D., appointed to Board of Directors</i></li></ul><p><span class="legendSpanClass"><location value="LU/us.ma.cambri" idsrc="xmltag.org" >CAMBRIDGE, Mass.</location></span>, <span class="legendSpanClass"><chron>July 17, 2024</chron></span> /PRNewswire/ -- <a target="_blank" href="https://c212.net/c/link/?t=0&amp;l=en&amp;o=4212926-1&amp;h=1027026365&amp;u=http%3A%2F%2Fwww.alltrna.com%2F&amp;a=Alltrna" target="_blank" rel="nofollow">Alltrna</a>, a Flagship Pioneering company unlocking transfer RNA (tRNA) biology and pioneering tRNA therapeutics to regulate the protein universe and resolve disease, today announced the appointment of <person value="APIN:1758666824">Chris Schade</person>, Growth Partner at Flagship Pioneering, as Chairperson of the Board, succeeding <person>Noubar Afeyan</person>, Ph.D., Co-Founder of Alltrna and Founder and CEO of Flagship Pioneering. In addition, Alltrna also announced the appointments http://www.streetinsider.com/Press+Releases/Alltrna+Announces+Updates+to+Its+Board+of+Directors/23472212.html Wed, 17 Jul 2024 08:00:00 -0400 2020 2023 A.01090263 A.13592230 A.27505448 A.27560722 A.27952506 A.35954321 A.40221050 A.40873631 A.50110756 A.50200199 APRE ARQL CYTK EVLO FHTX IART IONS MEDX MRNA NRG O.00016952 O.00095428 O.00134870 O.00170254 O.00170871 O.00174334 O.00644488 O.05654636 O.06732888 O.08438071 O.15696008 O.20042365 O.20737027 O.22555989 O.29788715 O.39449410 O.42040581 O.49002690 O.49824919 O.51354437 OMGA OMTH S1GE34 SANA SGEN SYRS http://www.streetinsider.com/Press+Releases/Alltrna+Announces+Updates+to+Its+Board+of+Directors/23472212.html <div class="xn-content"> <ul type="disc"><li><i><person value="APIN:1758666824">Chris Schade</person> appointed as Board Chairperson</i></li><li><i><person>Lynne Parshall</person>, <person>Robert Plenge</person>, M.D., Ph.D., and <person value="APIN:3936886864">Nancy Simonian</person>, M.D., appointed to Board of Directors</i></li></ul><p><span class="legendSpanClass"><location value="LU/us.ma.cambri" idsrc="xmltag.org" >CAMBRIDGE, Mass.</location></span>, <span class="legendSpanClass"><chron>July 17, 2024</chron></span> /PRNewswire/ -- <a target="_blank" href="https://c212.net/c/link/?t=0&amp;l=en&amp;o=4212926-1&amp;h=1027026365&amp;u=http%3A%2F%2Fwww.alltrna.com%2F&amp;a=Alltrna" target="_blank" rel="nofollow">Alltrna</a>, a Flagship Pioneering company unlocking transfer RNA (tRNA) biology and pioneering tRNA therapeutics to regulate the protein universe and resolve disease, today announced the appointment of <person value="APIN:1758666824">Chris Schade</person>, Growth Partner at Flagship Pioneering, as Chairperson of the Board, succeeding <person>Noubar Afeyan</person>, Ph.D., Co-Founder of Alltrna and Founder and CEO of Flagship Pioneering. In addition, Alltrna also announced the appointments http://www.streetinsider.com/Press+Releases/Alltrna+Announces+Updates+to+Its+Board+of+Directors/23472212.html Wed, 17 Jul 2024 08:00:00 -0400 2020 2023 A.01090263 A.13592230 A.27505448 A.27560722 A.27952506 A.35954321 A.40221050 A.40873631 A.50110756 A.50200199 APRE ARQL CYTK EVLO FHTX IART IONS MEDX MRNA NRG O.00016952 O.00095428 O.00134870 O.00170254 O.00170871 O.00174334 O.00644488 O.05654636 O.06732888 O.08438071 O.15696008 O.20042365 O.20737027 O.22555989 O.29788715 O.39449410 O.42040581 O.49002690 O.49824919 O.51354437 OMGA OMTH S1GE34 SANA SGEN SYRS http://www.streetinsider.com/Press+Releases/Alltrna+Announces+Updates+to+Its+Board+of+Directors/23472212.html <div class="xn-content"> <ul type="disc"><li><i><person value="APIN:1758666824">Chris Schade</person> appointed as Board Chairperson</i></li><li><i><person>Lynne Parshall</person>, <person>Robert Plenge</person>, M.D., Ph.D., and <person value="APIN:3936886864">Nancy Simonian</person>, M.D., appointed to Board of Directors</i></li></ul><p><span class="legendSpanClass"><location value="LU/us.ma.cambri" idsrc="xmltag.org" >CAMBRIDGE, Mass.</location></span>, <span class="legendSpanClass"><chron>July 17, 2024</chron></span> /PRNewswire/ -- <a target="_blank" href="https://c212.net/c/link/?t=0&amp;l=en&amp;o=4212926-1&amp;h=1027026365&amp;u=http%3A%2F%2Fwww.alltrna.com%2F&amp;a=Alltrna" target="_blank" rel="nofollow">Alltrna</a>, a Flagship Pioneering company unlocking transfer RNA (tRNA) biology and pioneering tRNA therapeutics to regulate the protein universe and resolve disease, today announced the appointment of <person value="APIN:1758666824">Chris Schade</person>, Growth Partner at Flagship Pioneering, as Chairperson of the Board, succeeding <person>Noubar Afeyan</person>, Ph.D., Co-Founder of Alltrna and Founder and CEO of Flagship Pioneering. In addition, Alltrna also announced the appointments http://www.streetinsider.com/Press+Releases/Alltrna+Announces+Updates+to+Its+Board+of+Directors/23472212.html Wed, 17 Jul 2024 08:00:00 -0400 2020 2023 A.01090263 A.13592230 A.27505448 A.27560722 A.27952506 A.35954321 A.40221050 A.40873631 A.50110756 A.50200199 APRE ARQL CYTK EVLO FHTX IART IONS MEDX MRNA NRG O.00016952 O.00095428 O.00134870 O.00170254 O.00170871 O.00174334 O.00644488 O.05654636 O.06732888 O.08438071 O.15696008 O.20042365 O.20737027 O.22555989 O.29788715 O.39449410 O.42040581 O.49002690 O.49824919 O.51354437 OMGA OMTH S1GE34 SANA SGEN SYRS http://www.streetinsider.com/Press+Releases/Alltrna+Announces+Updates+to+Its+Board+of+Directors/23472212.html <div class="xn-content"> <ul type="disc"><li><i><person value="APIN:1758666824">Chris Schade</person> appointed as Board Chairperson</i></li><li><i><person>Lynne Parshall</person>, <person>Robert Plenge</person>, M.D., Ph.D., and <person value="APIN:3936886864">Nancy Simonian</person>, M.D., appointed to Board of Directors</i></li></ul><p><span class="legendSpanClass"><location value="LU/us.ma.cambri" idsrc="xmltag.org" >CAMBRIDGE, Mass.</location></span>, <span class="legendSpanClass"><chron>July 17, 2024</chron></span> /PRNewswire/ -- <a target="_blank" href="https://c212.net/c/link/?t=0&amp;l=en&amp;o=4212926-1&amp;h=1027026365&amp;u=http%3A%2F%2Fwww.alltrna.com%2F&amp;a=Alltrna" target="_blank" rel="nofollow">Alltrna</a>, a Flagship Pioneering company unlocking transfer RNA (tRNA) biology and pioneering tRNA therapeutics to regulate the protein universe and resolve disease, today announced the appointment of <person value="APIN:1758666824">Chris Schade</person>, Growth Partner at Flagship Pioneering, as Chairperson of the Board, succeeding <person>Noubar Afeyan</person>, Ph.D., Co-Founder of Alltrna and Founder and CEO of Flagship Pioneering. In addition, Alltrna also announced the appointments http://www.streetinsider.com/Press+Releases/Alltrna+Announces+Updates+to+Its+Board+of+Directors/23472212.html Wed, 17 Jul 2024 08:00:00 -0400 2020 2023 A.01090263 A.13592230 A.27505448 A.27560722 A.27952506 A.35954321 A.40221050 A.40873631 A.50110756 A.50200199 APRE ARQL CYTK EVLO FHTX IART IONS MEDX MRNA NRG O.00016952 O.00095428 O.00134870 O.00170254 O.00170871 O.00174334 O.00644488 O.05654636 O.06732888 O.08438071 O.15696008 O.20042365 O.20737027 O.22555989 O.29788715 O.39449410 O.42040581 O.49002690 O.49824919 O.51354437 OMGA OMTH S1GE34 SANA SGEN SYRS http://www.streetinsider.com/Press+Releases/Alltrna+Announces+Updates+to+Its+Board+of+Directors/23472212.html <div class="xn-content"> <ul type="disc"><li><i><person value="APIN:1758666824">Chris Schade</person> appointed as Board Chairperson</i></li><li><i><person>Lynne Parshall</person>, <person>Robert Plenge</person>, M.D., Ph.D., and <person value="APIN:3936886864">Nancy Simonian</person>, M.D., appointed to Board of Directors</i></li></ul><p><span class="legendSpanClass"><location value="LU/us.ma.cambri" idsrc="xmltag.org" >CAMBRIDGE, Mass.</location></span>, <span class="legendSpanClass"><chron>July 17, 2024</chron></span> /PRNewswire/ -- <a target="_blank" href="https://c212.net/c/link/?t=0&amp;l=en&amp;o=4212926-1&amp;h=1027026365&amp;u=http%3A%2F%2Fwww.alltrna.com%2F&amp;a=Alltrna" target="_blank" rel="nofollow">Alltrna</a>, a Flagship Pioneering company unlocking transfer RNA (tRNA) biology and pioneering tRNA therapeutics to regulate the protein universe and resolve disease, today announced the appointment of <person value="APIN:1758666824">Chris Schade</person>, Growth Partner at Flagship Pioneering, as Chairperson of the Board, succeeding <person>Noubar Afeyan</person>, Ph.D., Co-Founder of Alltrna and Founder and CEO of Flagship Pioneering. In addition, Alltrna also announced the appointments http://www.streetinsider.com/Press+Releases/Alltrna+Announces+Updates+to+Its+Board+of+Directors/23472212.html Wed, 17 Jul 2024 08:00:00 -0400 2020 2023 A.01090263 A.13592230 A.27505448 A.27560722 A.27952506 A.35954321 A.40221050 A.40873631 A.50110756 A.50200199 APRE ARQL CYTK EVLO FHTX IART IONS MEDX MRNA NRG O.00016952 O.00095428 O.00134870 O.00170254 O.00170871 O.00174334 O.00644488 O.05654636 O.06732888 O.08438071 O.15696008 O.20042365 O.20737027 O.22555989 O.29788715 O.39449410 O.42040581 O.49002690 O.49824919 O.51354437 OMGA OMTH S1GE34 SANA SGEN SYRS http://www.streetinsider.com/Press+Releases/Alltrna+Announces+Updates+to+Its+Board+of+Directors/23472212.html <div class="xn-content"> <ul type="disc"><li><i><person value="APIN:1758666824">Chris Schade</person> appointed as Board Chairperson</i></li><li><i><person>Lynne Parshall</person>, <person>Robert Plenge</person>, M.D., Ph.D., and <person value="APIN:3936886864">Nancy Simonian</person>, M.D., appointed to Board of Directors</i></li></ul><p><span class="legendSpanClass"><location value="LU/us.ma.cambri" idsrc="xmltag.org" >CAMBRIDGE, Mass.</location></span>, <span class="legendSpanClass"><chron>July 17, 2024</chron></span> /PRNewswire/ -- <a target="_blank" href="https://c212.net/c/link/?t=0&amp;l=en&amp;o=4212926-1&amp;h=1027026365&amp;u=http%3A%2F%2Fwww.alltrna.com%2F&amp;a=Alltrna" target="_blank" rel="nofollow">Alltrna</a>, a Flagship Pioneering company unlocking transfer RNA (tRNA) biology and pioneering tRNA therapeutics to regulate the protein universe and resolve disease, today announced the appointment of <person value="APIN:1758666824">Chris Schade</person>, Growth Partner at Flagship Pioneering, as Chairperson of the Board, succeeding <person>Noubar Afeyan</person>, Ph.D., Co-Founder of Alltrna and Founder and CEO of Flagship Pioneering. In addition, Alltrna also announced the appointments http://www.streetinsider.com/Press+Releases/Alltrna+Announces+Updates+to+Its+Board+of+Directors/23472212.html Wed, 17 Jul 2024 08:00:00 -0400 2020 2023 A.01090263 A.13592230 A.27505448 A.27560722 A.27952506 A.35954321 A.40221050 A.40873631 A.50110756 A.50200199 APRE ARQL CYTK EVLO FHTX IART IONS MEDX MRNA NRG O.00016952 O.00095428 O.00134870 O.00170254 O.00170871 O.00174334 O.00644488 O.05654636 O.06732888 O.08438071 O.15696008 O.20042365 O.20737027 O.22555989 O.29788715 O.39449410 O.42040581 O.49002690 O.49824919 O.51354437 OMGA OMTH S1GE34 SANA SGEN SYRS http://www.streetinsider.com/Press+Releases/Alltrna+Announces+Updates+to+Its+Board+of+Directors/23472212.html <div class="xn-content"> <ul type="disc"><li><i><person value="APIN:1758666824">Chris Schade</person> appointed as Board Chairperson</i></li><li><i><person>Lynne Parshall</person>, <person>Robert Plenge</person>, M.D., Ph.D., and <person value="APIN:3936886864">Nancy Simonian</person>, M.D., appointed to Board of Directors</i></li></ul><p><span class="legendSpanClass"><location value="LU/us.ma.cambri" idsrc="xmltag.org" >CAMBRIDGE, Mass.</location></span>, <span class="legendSpanClass"><chron>July 17, 2024</chron></span> /PRNewswire/ -- <a target="_blank" href="https://c212.net/c/link/?t=0&amp;l=en&amp;o=4212926-1&amp;h=1027026365&amp;u=http%3A%2F%2Fwww.alltrna.com%2F&amp;a=Alltrna" target="_blank" rel="nofollow">Alltrna</a>, a Flagship Pioneering company unlocking transfer RNA (tRNA) biology and pioneering tRNA therapeutics to regulate the protein universe and resolve disease, today announced the appointment of <person value="APIN:1758666824">Chris Schade</person>, Growth Partner at Flagship Pioneering, as Chairperson of the Board, succeeding <person>Noubar Afeyan</person>, Ph.D., Co-Founder of Alltrna and Founder and CEO of Flagship Pioneering. In addition, Alltrna also announced the appointments http://www.streetinsider.com/Press+Releases/Alltrna+Announces+Updates+to+Its+Board+of+Directors/23472212.html Wed, 17 Jul 2024 08:00:00 -0400 2020 2023 A.01090263 A.13592230 A.27505448 A.27560722 A.27952506 A.35954321 A.40221050 A.40873631 A.50110756 A.50200199 APRE ARQL CYTK EVLO FHTX IART IONS MEDX MRNA NRG O.00016952 O.00095428 O.00134870 O.00170254 O.00170871 O.00174334 O.00644488 O.05654636 O.06732888 O.08438071 O.15696008 O.20042365 O.20737027 O.22555989 O.29788715 O.39449410 O.42040581 O.49002690 O.49824919 O.51354437 OMGA OMTH S1GE34 SANA SGEN SYRS http://www.streetinsider.com/Press+Releases/Alltrna+Announces+Updates+to+Its+Board+of+Directors/23472212.html <div class="xn-content"> <ul type="disc"><li><i><person value="APIN:1758666824">Chris Schade</person> appointed as Board Chairperson</i></li><li><i><person>Lynne Parshall</person>, <person>Robert Plenge</person>, M.D., Ph.D., and <person value="APIN:3936886864">Nancy Simonian</person>, M.D., appointed to Board of Directors</i></li></ul><p><span class="legendSpanClass"><location value="LU/us.ma.cambri" idsrc="xmltag.org" >CAMBRIDGE, Mass.</location></span>, <span class="legendSpanClass"><chron>July 17, 2024</chron></span> /PRNewswire/ -- <a target="_blank" href="https://c212.net/c/link/?t=0&amp;l=en&amp;o=4212926-1&amp;h=1027026365&amp;u=http%3A%2F%2Fwww.alltrna.com%2F&amp;a=Alltrna" target="_blank" rel="nofollow">Alltrna</a>, a Flagship Pioneering company unlocking transfer RNA (tRNA) biology and pioneering tRNA therapeutics to regulate the protein universe and resolve disease, today announced the appointment of <person value="APIN:1758666824">Chris Schade</person>, Growth Partner at Flagship Pioneering, as Chairperson of the Board, succeeding <person>Noubar Afeyan</person>, Ph.D., Co-Founder of Alltrna and Founder and CEO of Flagship Pioneering. In addition, Alltrna also announced the appointments http://www.streetinsider.com/Press+Releases/Alltrna+Announces+Updates+to+Its+Board+of+Directors/23472212.html Wed, 17 Jul 2024 08:00:00 -0400 2020 2023 A.01090263 A.13592230 A.27505448 A.27560722 A.27952506 A.35954321 A.40221050 A.40873631 A.50110756 A.50200199 APRE ARQL CYTK EVLO FHTX IART IONS MEDX MRNA NRG O.00016952 O.00095428 O.00134870 O.00170254 O.00170871 O.00174334 O.00644488 O.05654636 O.06732888 O.08438071 O.15696008 O.20042365 O.20737027 O.22555989 O.29788715 O.39449410 O.42040581 O.49002690 O.49824919 O.51354437 OMGA OMTH S1GE34 SANA SGEN SYRS http://www.streetinsider.com/Press+Releases/Alltrna+Announces+Updates+to+Its+Board+of+Directors/23472212.html <div class="xn-content"> <ul type="disc"><li><i><person value="APIN:1758666824">Chris Schade</person> appointed as Board Chairperson</i></li><li><i><person>Lynne Parshall</person>, <person>Robert Plenge</person>, M.D., Ph.D., and <person value="APIN:3936886864">Nancy Simonian</person>, M.D., appointed to Board of Directors</i></li></ul><p><span class="legendSpanClass"><location value="LU/us.ma.cambri" idsrc="xmltag.org" >CAMBRIDGE, Mass.</location></span>, <span class="legendSpanClass"><chron>July 17, 2024</chron></span> /PRNewswire/ -- <a target="_blank" href="https://c212.net/c/link/?t=0&amp;l=en&amp;o=4212926-1&amp;h=1027026365&amp;u=http%3A%2F%2Fwww.alltrna.com%2F&amp;a=Alltrna" target="_blank" rel="nofollow">Alltrna</a>, a Flagship Pioneering company unlocking transfer RNA (tRNA) biology and pioneering tRNA therapeutics to regulate the protein universe and resolve disease, today announced the appointment of <person value="APIN:1758666824">Chris Schade</person>, Growth Partner at Flagship Pioneering, as Chairperson of the Board, succeeding <person>Noubar Afeyan</person>, Ph.D., Co-Founder of Alltrna and Founder and CEO of Flagship Pioneering. In addition, Alltrna also announced the appointments http://www.streetinsider.com/Press+Releases/Alltrna+Announces+Updates+to+Its+Board+of+Directors/23472212.html Wed, 17 Jul 2024 08:00:00 -0400 2020 2023 A.01090263 A.13592230 A.27505448 A.27560722 A.27952506 A.35954321 A.40221050 A.40873631 A.50110756 A.50200199 APRE ARQL CYTK EVLO FHTX IART IONS MEDX MRNA NRG O.00016952 O.00095428 O.00134870 O.00170254 O.00170871 O.00174334 O.00644488 O.05654636 O.06732888 O.08438071 O.15696008 O.20042365 O.20737027 O.22555989 O.29788715 O.39449410 O.42040581 O.49002690 O.49824919 O.51354437 OMGA OMTH S1GE34 SANA SGEN SYRS http://www.streetinsider.com/Press+Releases/Alltrna+Announces+Updates+to+Its+Board+of+Directors/23472212.html <div class="xn-content"> <ul type="disc"><li><i><person value="APIN:1758666824">Chris Schade</person> appointed as Board Chairperson</i></li><li><i><person>Lynne Parshall</person>, <person>Robert Plenge</person>, M.D., Ph.D., and <person value="APIN:3936886864">Nancy Simonian</person>, M.D., appointed to Board of Directors</i></li></ul><p><span class="legendSpanClass"><location value="LU/us.ma.cambri" idsrc="xmltag.org" >CAMBRIDGE, Mass.</location></span>, <span class="legendSpanClass"><chron>July 17, 2024</chron></span> /PRNewswire/ -- <a target="_blank" href="https://c212.net/c/link/?t=0&amp;l=en&amp;o=4212926-1&amp;h=1027026365&amp;u=http%3A%2F%2Fwww.alltrna.com%2F&amp;a=Alltrna" target="_blank" rel="nofollow">Alltrna</a>, a Flagship Pioneering company unlocking transfer RNA (tRNA) biology and pioneering tRNA therapeutics to regulate the protein universe and resolve disease, today announced the appointment of <person value="APIN:1758666824">Chris Schade</person>, Growth Partner at Flagship Pioneering, as Chairperson of the Board, succeeding <person>Noubar Afeyan</person>, Ph.D., Co-Founder of Alltrna and Founder and CEO of Flagship Pioneering. In addition, Alltrna also announced the appointments http://www.streetinsider.com/Press+Releases/Alltrna+Announces+Updates+to+Its+Board+of+Directors/23472212.html Wed, 17 Jul 2024 08:00:00 -0400 2020 2023 A.01090263 A.13592230 A.27505448 A.27560722 A.27952506 A.35954321 A.40221050 A.40873631 A.50110756 A.50200199 APRE ARQL CYTK EVLO FHTX IART IONS MEDX MRNA NRG O.00016952 O.00095428 O.00134870 O.00170254 O.00170871 O.00174334 O.00644488 O.05654636 O.06732888 O.08438071 O.15696008 O.20042365 O.20737027 O.22555989 O.29788715 O.39449410 O.42040581 O.49002690 O.49824919 O.51354437 OMGA OMTH S1GE34 SANA SGEN SYRS http://www.streetinsider.com/Press+Releases/Alltrna+Announces+Updates+to+Its+Board+of+Directors/23472212.html <div class="xn-content"> <ul type="disc"><li><i><person value="APIN:1758666824">Chris Schade</person> appointed as Board Chairperson</i></li><li><i><person>Lynne Parshall</person>, <person>Robert Plenge</person>, M.D., Ph.D., and <person value="APIN:3936886864">Nancy Simonian</person>, M.D., appointed to Board of Directors</i></li></ul><p><span class="legendSpanClass"><location value="LU/us.ma.cambri" idsrc="xmltag.org" >CAMBRIDGE, Mass.</location></span>, <span class="legendSpanClass"><chron>July 17, 2024</chron></span> /PRNewswire/ -- <a target="_blank" href="https://c212.net/c/link/?t=0&amp;l=en&amp;o=4212926-1&amp;h=1027026365&amp;u=http%3A%2F%2Fwww.alltrna.com%2F&amp;a=Alltrna" target="_blank" rel="nofollow">Alltrna</a>, a Flagship Pioneering company unlocking transfer RNA (tRNA) biology and pioneering tRNA therapeutics to regulate the protein universe and resolve disease, today announced the appointment of <person value="APIN:1758666824">Chris Schade</person>, Growth Partner at Flagship Pioneering, as Chairperson of the Board, succeeding <person>Noubar Afeyan</person>, Ph.D., Co-Founder of Alltrna and Founder and CEO of Flagship Pioneering. In addition, Alltrna also announced the appointments http://www.streetinsider.com/Press+Releases/Alltrna+Announces+Updates+to+Its+Board+of+Directors/23472212.html Wed, 17 Jul 2024 08:00:00 -0400 2020 2023 A.01090263 A.13592230 A.27505448 A.27560722 A.27952506 A.35954321 A.40221050 A.40873631 A.50110756 A.50200199 APRE ARQL CYTK EVLO FHTX IART IONS MEDX MRNA NRG O.00016952 O.00095428 O.00134870 O.00170254 O.00170871 O.00174334 O.00644488 O.05654636 O.06732888 O.08438071 O.15696008 O.20042365 O.20737027 O.22555989 O.29788715 O.39449410 O.42040581 O.49002690 O.49824919 O.51354437 OMGA OMTH S1GE34 SANA SGEN SYRS http://www.streetinsider.com/Press+Releases/Alltrna+Announces+Updates+to+Its+Board+of+Directors/23472212.html <div class="xn-content"> <ul type="disc"><li><i><person value="APIN:1758666824">Chris Schade</person> appointed as Board Chairperson</i></li><li><i><person>Lynne Parshall</person>, <person>Robert Plenge</person>, M.D., Ph.D., and <person value="APIN:3936886864">Nancy Simonian</person>, M.D., appointed to Board of Directors</i></li></ul><p><span class="legendSpanClass"><location value="LU/us.ma.cambri" idsrc="xmltag.org" >CAMBRIDGE, Mass.</location></span>, <span class="legendSpanClass"><chron>July 17, 2024</chron></span> /PRNewswire/ -- <a target="_blank" href="https://c212.net/c/link/?t=0&amp;l=en&amp;o=4212926-1&amp;h=1027026365&amp;u=http%3A%2F%2Fwww.alltrna.com%2F&amp;a=Alltrna" target="_blank" rel="nofollow">Alltrna</a>, a Flagship Pioneering company unlocking transfer RNA (tRNA) biology and pioneering tRNA therapeutics to regulate the protein universe and resolve disease, today announced the appointment of <person value="APIN:1758666824">Chris Schade</person>, Growth Partner at Flagship Pioneering, as Chairperson of the Board, succeeding <person>Noubar Afeyan</person>, Ph.D., Co-Founder of Alltrna and Founder and CEO of Flagship Pioneering. In addition, Alltrna also announced the appointments http://www.streetinsider.com/Press+Releases/Alltrna+Announces+Updates+to+Its+Board+of+Directors/23472212.html Wed, 17 Jul 2024 08:00:00 -0400 2020 2023 A.01090263 A.13592230 A.27505448 A.27560722 A.27952506 A.35954321 A.40221050 A.40873631 A.50110756 A.50200199 APRE ARQL CYTK EVLO FHTX IART IONS MEDX MRNA NRG O.00016952 O.00095428 O.00134870 O.00170254 O.00170871 O.00174334 O.00644488 O.05654636 O.06732888 O.08438071 O.15696008 O.20042365 O.20737027 O.22555989 O.29788715 O.39449410 O.42040581 O.49002690 O.49824919 O.51354437 OMGA OMTH S1GE34 SANA SGEN SYRS http://www.streetinsider.com/Press+Releases/Alltrna+Announces+Updates+to+Its+Board+of+Directors/23472212.html <div class="xn-content"> <ul type="disc"><li><i><person value="APIN:1758666824">Chris Schade</person> appointed as Board Chairperson</i></li><li><i><person>Lynne Parshall</person>, <person>Robert Plenge</person>, M.D., Ph.D., and <person value="APIN:3936886864">Nancy Simonian</person>, M.D., appointed to Board of Directors</i></li></ul><p><span class="legendSpanClass"><location value="LU/us.ma.cambri" idsrc="xmltag.org" >CAMBRIDGE, Mass.</location></span>, <span class="legendSpanClass"><chron>July 17, 2024</chron></span> /PRNewswire/ -- <a target="_blank" href="https://c212.net/c/link/?t=0&amp;l=en&amp;o=4212926-1&amp;h=1027026365&amp;u=http%3A%2F%2Fwww.alltrna.com%2F&amp;a=Alltrna" target="_blank" rel="nofollow">Alltrna</a>, a Flagship Pioneering company unlocking transfer RNA (tRNA) biology and pioneering tRNA therapeutics to regulate the protein universe and resolve disease, today announced the appointment of <person value="APIN:1758666824">Chris Schade</person>, Growth Partner at Flagship Pioneering, as Chairperson of the Board, succeeding <person>Noubar Afeyan</person>, Ph.D., Co-Founder of Alltrna and Founder and CEO of Flagship Pioneering. In addition, Alltrna also announced the appointments http://www.streetinsider.com/Press+Releases/Alltrna+Announces+Updates+to+Its+Board+of+Directors/23472212.html Wed, 17 Jul 2024 08:00:00 -0400 2020 2023 A.01090263 A.13592230 A.27505448 A.27560722 A.27952506 A.35954321 A.40221050 A.40873631 A.50110756 A.50200199 APRE ARQL CYTK EVLO FHTX IART IONS MEDX MRNA NRG O.00016952 O.00095428 O.00134870 O.00170254 O.00170871 O.00174334 O.00644488 O.05654636 O.06732888 O.08438071 O.15696008 O.20042365 O.20737027 O.22555989 O.29788715 O.39449410 O.42040581 O.49002690 O.49824919 O.51354437 OMGA OMTH S1GE34 SANA SGEN SYRS http://www.streetinsider.com/Press+Releases/Alltrna+Announces+Updates+to+Its+Board+of+Directors/23472212.html <div class="xn-content"> <ul type="disc"><li><i><person value="APIN:1758666824">Chris Schade</person> appointed as Board Chairperson</i></li><li><i><person>Lynne Parshall</person>, <person>Robert Plenge</person>, M.D., Ph.D., and <person value="APIN:3936886864">Nancy Simonian</person>, M.D., appointed to Board of Directors</i></li></ul><p><span class="legendSpanClass"><location value="LU/us.ma.cambri" idsrc="xmltag.org" >CAMBRIDGE, Mass.</location></span>, <span class="legendSpanClass"><chron>July 17, 2024</chron></span> /PRNewswire/ -- <a target="_blank" href="https://c212.net/c/link/?t=0&amp;l=en&amp;o=4212926-1&amp;h=1027026365&amp;u=http%3A%2F%2Fwww.alltrna.com%2F&amp;a=Alltrna" target="_blank" rel="nofollow">Alltrna</a>, a Flagship Pioneering company unlocking transfer RNA (tRNA) biology and pioneering tRNA therapeutics to regulate the protein universe and resolve disease, today announced the appointment of <person value="APIN:1758666824">Chris Schade</person>, Growth Partner at Flagship Pioneering, as Chairperson of the Board, succeeding <person>Noubar Afeyan</person>, Ph.D., Co-Founder of Alltrna and Founder and CEO of Flagship Pioneering. In addition, Alltrna also announced the appointments http://www.streetinsider.com/Press+Releases/Alltrna+Announces+Updates+to+Its+Board+of+Directors/23472212.html Wed, 17 Jul 2024 08:00:00 -0400 2020 2023 A.01090263 A.13592230 A.27505448 A.27560722 A.27952506 A.35954321 A.40221050 A.40873631 A.50110756 A.50200199 APRE ARQL CYTK EVLO FHTX IART IONS MEDX MRNA NRG O.00016952 O.00095428 O.00134870 O.00170254 O.00170871 O.00174334 O.00644488 O.05654636 O.06732888 O.08438071 O.15696008 O.20042365 O.20737027 O.22555989 O.29788715 O.39449410 O.42040581 O.49002690 O.49824919 O.51354437 OMGA OMTH S1GE34 SANA SGEN SYRS http://www.streetinsider.com/Press+Releases/Alltrna+Announces+Updates+to+Its+Board+of+Directors/23472212.html <div class="xn-content"> <ul type="disc"><li><i><person value="APIN:1758666824">Chris Schade</person> appointed as Board Chairperson</i></li><li><i><person>Lynne Parshall</person>, <person>Robert Plenge</person>, M.D., Ph.D., and <person value="APIN:3936886864">Nancy Simonian</person>, M.D., appointed to Board of Directors</i></li></ul><p><span class="legendSpanClass"><location value="LU/us.ma.cambri" idsrc="xmltag.org" >CAMBRIDGE, Mass.</location></span>, <span class="legendSpanClass"><chron>July 17, 2024</chron></span> /PRNewswire/ -- <a target="_blank" href="https://c212.net/c/link/?t=0&amp;l=en&amp;o=4212926-1&amp;h=1027026365&amp;u=http%3A%2F%2Fwww.alltrna.com%2F&amp;a=Alltrna" target="_blank" rel="nofollow">Alltrna</a>, a Flagship Pioneering company unlocking transfer RNA (tRNA) biology and pioneering tRNA therapeutics to regulate the protein universe and resolve disease, today announced the appointment of <person value="APIN:1758666824">Chris Schade</person>, Growth Partner at Flagship Pioneering, as Chairperson of the Board, succeeding <person>Noubar Afeyan</person>, Ph.D., Co-Founder of Alltrna and Founder and CEO of Flagship Pioneering. In addition, Alltrna also announced the appointments http://www.streetinsider.com/Press+Releases/Alltrna+Announces+Updates+to+Its+Board+of+Directors/23472212.html Wed, 17 Jul 2024 08:00:00 -0400 2020 2023 A.01090263 A.13592230 A.27505448 A.27560722 A.27952506 A.35954321 A.40221050 A.40873631 A.50110756 A.50200199 APRE ARQL CYTK EVLO FHTX IART IONS MEDX MRNA NRG O.00016952 O.00095428 O.00134870 O.00170254 O.00170871 O.00174334 O.00644488 O.05654636 O.06732888 O.08438071 O.15696008 O.20042365 O.20737027 O.22555989 O.29788715 O.39449410 O.42040581 O.49002690 O.49824919 O.51354437 OMGA OMTH S1GE34 SANA SGEN SYRS http://www.streetinsider.com/Press+Releases/Alltrna+Announces+Updates+to+Its+Board+of+Directors/23472212.html <div class="xn-content"> <ul type="disc"><li><i><person value="APIN:1758666824">Chris Schade</person> appointed as Board Chairperson</i></li><li><i><person>Lynne Parshall</person>, <person>Robert Plenge</person>, M.D., Ph.D., and <person value="APIN:3936886864">Nancy Simonian</person>, M.D., appointed to Board of Directors</i></li></ul><p><span class="legendSpanClass"><location value="LU/us.ma.cambri" idsrc="xmltag.org" >CAMBRIDGE, Mass.</location></span>, <span class="legendSpanClass"><chron>July 17, 2024</chron></span> /PRNewswire/ -- <a target="_blank" href="https://c212.net/c/link/?t=0&amp;l=en&amp;o=4212926-1&amp;h=1027026365&amp;u=http%3A%2F%2Fwww.alltrna.com%2F&amp;a=Alltrna" target="_blank" rel="nofollow">Alltrna</a>, a Flagship Pioneering company unlocking transfer RNA (tRNA) biology and pioneering tRNA therapeutics to regulate the protein universe and resolve disease, today announced the appointment of <person value="APIN:1758666824">Chris Schade</person>, Growth Partner at Flagship Pioneering, as Chairperson of the Board, succeeding <person>Noubar Afeyan</person>, Ph.D., Co-Founder of Alltrna and Founder and CEO of Flagship Pioneering. In addition, Alltrna also announced the appointments http://www.streetinsider.com/Press+Releases/Alltrna+Announces+Updates+to+Its+Board+of+Directors/23472212.html Wed, 17 Jul 2024 08:00:00 -0400 2020 2023 A.01090263 A.13592230 A.27505448 A.27560722 A.27952506 A.35954321 A.40221050 A.40873631 A.50110756 A.50200199 APRE ARQL CYTK EVLO FHTX IART IONS MEDX MRNA NRG O.00016952 O.00095428 O.00134870 O.00170254 O.00170871 O.00174334 O.00644488 O.05654636 O.06732888 O.08438071 O.15696008 O.20042365 O.20737027 O.22555989 O.29788715 O.39449410 O.42040581 O.49002690 O.49824919 O.51354437 OMGA OMTH S1GE34 SANA SGEN SYRS http://www.streetinsider.com/Press+Releases/Alltrna+Announces+Updates+to+Its+Board+of+Directors/23472212.html <div class="xn-content"> <ul type="disc"><li><i><person value="APIN:1758666824">Chris Schade</person> appointed as Board Chairperson</i></li><li><i><person>Lynne Parshall</person>, <person>Robert Plenge</person>, M.D., Ph.D., and <person value="APIN:3936886864">Nancy Simonian</person>, M.D., appointed to Board of Directors</i></li></ul><p><span class="legendSpanClass"><location value="LU/us.ma.cambri" idsrc="xmltag.org" >CAMBRIDGE, Mass.</location></span>, <span class="legendSpanClass"><chron>July 17, 2024</chron></span> /PRNewswire/ -- <a target="_blank" href="https://c212.net/c/link/?t=0&amp;l=en&amp;o=4212926-1&amp;h=1027026365&amp;u=http%3A%2F%2Fwww.alltrna.com%2F&amp;a=Alltrna" target="_blank" rel="nofollow">Alltrna</a>, a Flagship Pioneering company unlocking transfer RNA (tRNA) biology and pioneering tRNA therapeutics to regulate the protein universe and resolve disease, today announced the appointment of <person value="APIN:1758666824">Chris Schade</person>, Growth Partner at Flagship Pioneering, as Chairperson of the Board, succeeding <person>Noubar Afeyan</person>, Ph.D., Co-Founder of Alltrna and Founder and CEO of Flagship Pioneering. In addition, Alltrna also announced the appointments http://www.streetinsider.com/Press+Releases/Alltrna+Announces+Updates+to+Its+Board+of+Directors/23472212.html Wed, 17 Jul 2024 08:00:00 -0400 2020 2023 A.01090263 A.13592230 A.27505448 A.27560722 A.27952506 A.35954321 A.40221050 A.40873631 A.50110756 A.50200199 APRE ARQL CYTK EVLO FHTX IART IONS MEDX MRNA NRG O.00016952 O.00095428 O.00134870 O.00170254 O.00170871 O.00174334 O.00644488 O.05654636 O.06732888 O.08438071 O.15696008 O.20042365 O.20737027 O.22555989 O.29788715 O.39449410 O.42040581 O.49002690 O.49824919 O.51354437 OMGA OMTH S1GE34 SANA SGEN SYRS http://www.streetinsider.com/Press+Releases/Alltrna+Announces+Updates+to+Its+Board+of+Directors/23472212.html <div class="xn-content"> <ul type="disc"><li><i><person value="APIN:1758666824">Chris Schade</person> appointed as Board Chairperson</i></li><li><i><person>Lynne Parshall</person>, <person>Robert Plenge</person>, M.D., Ph.D., and <person value="APIN:3936886864">Nancy Simonian</person>, M.D., appointed to Board of Directors</i></li></ul><p><span class="legendSpanClass"><location value="LU/us.ma.cambri" idsrc="xmltag.org" >CAMBRIDGE, Mass.</location></span>, <span class="legendSpanClass"><chron>July 17, 2024</chron></span> /PRNewswire/ -- <a target="_blank" href="https://c212.net/c/link/?t=0&amp;l=en&amp;o=4212926-1&amp;h=1027026365&amp;u=http%3A%2F%2Fwww.alltrna.com%2F&amp;a=Alltrna" target="_blank" rel="nofollow">Alltrna</a>, a Flagship Pioneering company unlocking transfer RNA (tRNA) biology and pioneering tRNA therapeutics to regulate the protein universe and resolve disease, today announced the appointment of <person value="APIN:1758666824">Chris Schade</person>, Growth Partner at Flagship Pioneering, as Chairperson of the Board, succeeding <person>Noubar Afeyan</person>, Ph.D., Co-Founder of Alltrna and Founder and CEO of Flagship Pioneering. In addition, Alltrna also announced the appointments http://www.streetinsider.com/Press+Releases/Alltrna+Announces+Updates+to+Its+Board+of+Directors/23472212.html Wed, 17 Jul 2024 08:00:00 -0400 2020 2023 A.01090263 A.13592230 A.27505448 A.27560722 A.27952506 A.35954321 A.40221050 A.40873631 A.50110756 A.50200199 APRE ARQL CYTK EVLO FHTX IART IONS MEDX MRNA NRG O.00016952 O.00095428 O.00134870 O.00170254 O.00170871 O.00174334 O.00644488 O.05654636 O.06732888 O.08438071 O.15696008 O.20042365 O.20737027 O.22555989 O.29788715 O.39449410 O.42040581 O.49002690 O.49824919 O.51354437 OMGA OMTH S1GE34 SANA SGEN SYRS http://www.streetinsider.com/Press+Releases/Alltrna+Announces+Updates+to+Its+Board+of+Directors/23472212.html <div class="xn-content"> <ul type="disc"><li><i><person value="APIN:1758666824">Chris Schade</person> appointed as Board Chairperson</i></li><li><i><person>Lynne Parshall</person>, <person>Robert Plenge</person>, M.D., Ph.D., and <person value="APIN:3936886864">Nancy Simonian</person>, M.D., appointed to Board of Directors</i></li></ul><p><span class="legendSpanClass"><location value="LU/us.ma.cambri" idsrc="xmltag.org" >CAMBRIDGE, Mass.</location></span>, <span class="legendSpanClass"><chron>July 17, 2024</chron></span> /PRNewswire/ -- <a target="_blank" href="https://c212.net/c/link/?t=0&amp;l=en&amp;o=4212926-1&amp;h=1027026365&amp;u=http%3A%2F%2Fwww.alltrna.com%2F&amp;a=Alltrna" target="_blank" rel="nofollow">Alltrna</a>, a Flagship Pioneering company unlocking transfer RNA (tRNA) biology and pioneering tRNA therapeutics to regulate the protein universe and resolve disease, today announced the appointment of <person value="APIN:1758666824">Chris Schade</person>, Growth Partner at Flagship Pioneering, as Chairperson of the Board, succeeding <person>Noubar Afeyan</person>, Ph.D., Co-Founder of Alltrna and Founder and CEO of Flagship Pioneering. In addition, Alltrna also announced the appointments http://www.streetinsider.com/Press+Releases/Alltrna+Announces+Updates+to+Its+Board+of+Directors/23472212.html Wed, 17 Jul 2024 08:00:00 -0400 2020 2023 A.01090263 A.13592230 A.27505448 A.27560722 A.27952506 A.35954321 A.40221050 A.40873631 A.50110756 A.50200199 APRE ARQL CYTK EVLO FHTX IART IONS MEDX MRNA NRG O.00016952 O.00095428 O.00134870 O.00170254 O.00170871 O.00174334 O.00644488 O.05654636 O.06732888 O.08438071 O.15696008 O.20042365 O.20737027 O.22555989 O.29788715 O.39449410 O.42040581 O.49002690 O.49824919 O.51354437 OMGA OMTH S1GE34 SANA SGEN SYRS http://www.streetinsider.com/Press+Releases/Alltrna+Announces+Updates+to+Its+Board+of+Directors/23472212.html <div class="xn-content"> <ul type="disc"><li><i><person value="APIN:1758666824">Chris Schade</person> appointed as Board Chairperson</i></li><li><i><person>Lynne Parshall</person>, <person>Robert Plenge</person>, M.D., Ph.D., and <person value="APIN:3936886864">Nancy Simonian</person>, M.D., appointed to Board of Directors</i></li></ul><p><span class="legendSpanClass"><location value="LU/us.ma.cambri" idsrc="xmltag.org" >CAMBRIDGE, Mass.</location></span>, <span class="legendSpanClass"><chron>July 17, 2024</chron></span> /PRNewswire/ -- <a target="_blank" href="https://c212.net/c/link/?t=0&amp;l=en&amp;o=4212926-1&amp;h=1027026365&amp;u=http%3A%2F%2Fwww.alltrna.com%2F&amp;a=Alltrna" target="_blank" rel="nofollow">Alltrna</a>, a Flagship Pioneering company unlocking transfer RNA (tRNA) biology and pioneering tRNA therapeutics to regulate the protein universe and resolve disease, today announced the appointment of <person value="APIN:1758666824">Chris Schade</person>, Growth Partner at Flagship Pioneering, as Chairperson of the Board, succeeding <person>Noubar Afeyan</person>, Ph.D., Co-Founder of Alltrna and Founder and CEO of Flagship Pioneering. In addition, Alltrna also announced the appointments http://www.streetinsider.com/Press+Releases/Alltrna+Announces+Updates+to+Its+Board+of+Directors/23472212.html Wed, 17 Jul 2024 08:00:00 -0400 2020 2023 A.01090263 A.13592230 A.27505448 A.27560722 A.27952506 A.35954321 A.40221050 A.40873631 A.50110756 A.50200199 APRE ARQL CYTK EVLO FHTX IART IONS MEDX MRNA NRG O.00016952 O.00095428 O.00134870 O.00170254 O.00170871 O.00174334 O.00644488 O.05654636 O.06732888 O.08438071 O.15696008 O.20042365 O.20737027 O.22555989 O.29788715 O.39449410 O.42040581 O.49002690 O.49824919 O.51354437 OMGA OMTH S1GE34 SANA SGEN SYRS http://www.streetinsider.com/Press+Releases/Alltrna+Announces+Updates+to+Its+Board+of+Directors/23472212.html <div class="xn-content"> <ul type="disc"><li><i><person value="APIN:1758666824">Chris Schade</person> appointed as Board Chairperson</i></li><li><i><person>Lynne Parshall</person>, <person>Robert Plenge</person>, M.D., Ph.D., and <person value="APIN:3936886864">Nancy Simonian</person>, M.D., appointed to Board of Directors</i></li></ul><p><span class="legendSpanClass"><location value="LU/us.ma.cambri" idsrc="xmltag.org" >CAMBRIDGE, Mass.</location></span>, <span class="legendSpanClass"><chron>July 17, 2024</chron></span> /PRNewswire/ -- <a target="_blank" href="https://c212.net/c/link/?t=0&amp;l=en&amp;o=4212926-1&amp;h=1027026365&amp;u=http%3A%2F%2Fwww.alltrna.com%2F&amp;a=Alltrna" target="_blank" rel="nofollow">Alltrna</a>, a Flagship Pioneering company unlocking transfer RNA (tRNA) biology and pioneering tRNA therapeutics to regulate the protein universe and resolve disease, today announced the appointment of <person value="APIN:1758666824">Chris Schade</person>, Growth Partner at Flagship Pioneering, as Chairperson of the Board, succeeding <person>Noubar Afeyan</person>, Ph.D., Co-Founder of Alltrna and Founder and CEO of Flagship Pioneering. In addition, Alltrna also announced the appointments http://www.streetinsider.com/Press+Releases/Alltrna+Announces+Updates+to+Its+Board+of+Directors/23472212.html Wed, 17 Jul 2024 08:00:00 -0400 2020 2023 A.01090263 A.13592230 A.27505448 A.27560722 A.27952506 A.35954321 A.40221050 A.40873631 A.50110756 A.50200199 APRE ARQL CYTK EVLO FHTX IART IONS MEDX MRNA NRG O.00016952 O.00095428 O.00134870 O.00170254 O.00170871 O.00174334 O.00644488 O.05654636 O.06732888 O.08438071 O.15696008 O.20042365 O.20737027 O.22555989 O.29788715 O.39449410 O.42040581 O.49002690 O.49824919 O.51354437 OMGA OMTH S1GE34 SANA SGEN SYRS http://www.streetinsider.com/Press+Releases/Alltrna+Announces+Updates+to+Its+Board+of+Directors/23472212.html <div class="xn-content"> <ul type="disc"><li><i><person value="APIN:1758666824">Chris Schade</person> appointed as Board Chairperson</i></li><li><i><person>Lynne Parshall</person>, <person>Robert Plenge</person>, M.D., Ph.D., and <person value="APIN:3936886864">Nancy Simonian</person>, M.D., appointed to Board of Directors</i></li></ul><p><span class="legendSpanClass"><location value="LU/us.ma.cambri" idsrc="xmltag.org" >CAMBRIDGE, Mass.</location></span>, <span class="legendSpanClass"><chron>July 17, 2024</chron></span> /PRNewswire/ -- <a target="_blank" href="https://c212.net/c/link/?t=0&amp;l=en&amp;o=4212926-1&amp;h=1027026365&amp;u=http%3A%2F%2Fwww.alltrna.com%2F&amp;a=Alltrna" target="_blank" rel="nofollow">Alltrna</a>, a Flagship Pioneering company unlocking transfer RNA (tRNA) biology and pioneering tRNA therapeutics to regulate the protein universe and resolve disease, today announced the appointment of <person value="APIN:1758666824">Chris Schade</person>, Growth Partner at Flagship Pioneering, as Chairperson of the Board, succeeding <person>Noubar Afeyan</person>, Ph.D., Co-Founder of Alltrna and Founder and CEO of Flagship Pioneering. In addition, Alltrna also announced the appointments http://www.streetinsider.com/Press+Releases/Alltrna+Announces+Updates+to+Its+Board+of+Directors/23472212.html Wed, 17 Jul 2024 08:00:00 -0400 2020 2023 A.01090263 A.13592230 A.27505448 A.27560722 A.27952506 A.35954321 A.40221050 A.40873631 A.50110756 A.50200199 APRE ARQL CYTK EVLO FHTX IART IONS MEDX MRNA NRG O.00016952 O.00095428 O.00134870 O.00170254 O.00170871 O.00174334 O.00644488 O.05654636 O.06732888 O.08438071 O.15696008 O.20042365 O.20737027 O.22555989 O.29788715 O.39449410 O.42040581 O.49002690 O.49824919 O.51354437 OMGA OMTH S1GE34 SANA SGEN SYRS http://www.streetinsider.com/Press+Releases/Alltrna+Announces+Updates+to+Its+Board+of+Directors/23472212.html <div class="xn-content"> <ul type="disc"><li><i><person value="APIN:1758666824">Chris Schade</person> appointed as Board Chairperson</i></li><li><i><person>Lynne Parshall</person>, <person>Robert Plenge</person>, M.D., Ph.D., and <person value="APIN:3936886864">Nancy Simonian</person>, M.D., appointed to Board of Directors</i></li></ul><p><span class="legendSpanClass"><location value="LU/us.ma.cambri" idsrc="xmltag.org" >CAMBRIDGE, Mass.</location></span>, <span class="legendSpanClass"><chron>July 17, 2024</chron></span> /PRNewswire/ -- <a target="_blank" href="https://c212.net/c/link/?t=0&amp;l=en&amp;o=4212926-1&amp;h=1027026365&amp;u=http%3A%2F%2Fwww.alltrna.com%2F&amp;a=Alltrna" target="_blank" rel="nofollow">Alltrna</a>, a Flagship Pioneering company unlocking transfer RNA (tRNA) biology and pioneering tRNA therapeutics to regulate the protein universe and resolve disease, today announced the appointment of <person value="APIN:1758666824">Chris Schade</person>, Growth Partner at Flagship Pioneering, as Chairperson of the Board, succeeding <person>Noubar Afeyan</person>, Ph.D., Co-Founder of Alltrna and Founder and CEO of Flagship Pioneering. In addition, Alltrna also announced the appointments http://www.streetinsider.com/Press+Releases/Alltrna+Announces+Updates+to+Its+Board+of+Directors/23472212.html Wed, 17 Jul 2024 08:00:00 -0400 2020 2023 A.01090263 A.13592230 A.27505448 A.27560722 A.27952506 A.35954321 A.40221050 A.40873631 A.50110756 A.50200199 APRE ARQL CYTK EVLO FHTX IART IONS MEDX MRNA NRG O.00016952 O.00095428 O.00134870 O.00170254 O.00170871 O.00174334 O.00644488 O.05654636 O.06732888 O.08438071 O.15696008 O.20042365 O.20737027 O.22555989 O.29788715 O.39449410 O.42040581 O.49002690 O.49824919 O.51354437 OMGA OMTH S1GE34 SANA SGEN SYRS http://www.streetinsider.com/Press+Releases/Alltrna+Announces+Updates+to+Its+Board+of+Directors/23472212.html <div class="xn-content"> <ul type="disc"><li><i><person value="APIN:1758666824">Chris Schade</person> appointed as Board Chairperson</i></li><li><i><person>Lynne Parshall</person>, <person>Robert Plenge</person>, M.D., Ph.D., and <person value="APIN:3936886864">Nancy Simonian</person>, M.D., appointed to Board of Directors</i></li></ul><p><span class="legendSpanClass"><location value="LU/us.ma.cambri" idsrc="xmltag.org" >CAMBRIDGE, Mass.</location></span>, <span class="legendSpanClass"><chron>July 17, 2024</chron></span> /PRNewswire/ -- <a target="_blank" href="https://c212.net/c/link/?t=0&amp;l=en&amp;o=4212926-1&amp;h=1027026365&amp;u=http%3A%2F%2Fwww.alltrna.com%2F&amp;a=Alltrna" target="_blank" rel="nofollow">Alltrna</a>, a Flagship Pioneering company unlocking transfer RNA (tRNA) biology and pioneering tRNA therapeutics to regulate the protein universe and resolve disease, today announced the appointment of <person value="APIN:1758666824">Chris Schade</person>, Growth Partner at Flagship Pioneering, as Chairperson of the Board, succeeding <person>Noubar Afeyan</person>, Ph.D., Co-Founder of Alltrna and Founder and CEO of Flagship Pioneering. In addition, Alltrna also announced the appointments http://www.streetinsider.com/Press+Releases/Alltrna+Announces+Updates+to+Its+Board+of+Directors/23472212.html Wed, 17 Jul 2024 08:00:00 -0400 2020 2023 A.01090263 A.13592230 A.27505448 A.27560722 A.27952506 A.35954321 A.40221050 A.40873631 A.50110756 A.50200199 APRE ARQL CYTK EVLO FHTX IART IONS MEDX MRNA NRG O.00016952 O.00095428 O.00134870 O.00170254 O.00170871 O.00174334 O.00644488 O.05654636 O.06732888 O.08438071 O.15696008 O.20042365 O.20737027 O.22555989 O.29788715 O.39449410 O.42040581 O.49002690 O.49824919 O.51354437 OMGA OMTH S1GE34 SANA SGEN SYRS http://www.streetinsider.com/Press+Releases/Alltrna+Announces+Updates+to+Its+Board+of+Directors/23472212.html <div class="xn-content"> <ul type="disc"><li><i><person value="APIN:1758666824">Chris Schade</person> appointed as Board Chairperson</i></li><li><i><person>Lynne Parshall</person>, <person>Robert Plenge</person>, M.D., Ph.D., and <person value="APIN:3936886864">Nancy Simonian</person>, M.D., appointed to Board of Directors</i></li></ul><p><span class="legendSpanClass"><location value="LU/us.ma.cambri" idsrc="xmltag.org" >CAMBRIDGE, Mass.</location></span>, <span class="legendSpanClass"><chron>July 17, 2024</chron></span> /PRNewswire/ -- <a target="_blank" href="https://c212.net/c/link/?t=0&amp;l=en&amp;o=4212926-1&amp;h=1027026365&amp;u=http%3A%2F%2Fwww.alltrna.com%2F&amp;a=Alltrna" target="_blank" rel="nofollow">Alltrna</a>, a Flagship Pioneering company unlocking transfer RNA (tRNA) biology and pioneering tRNA therapeutics to regulate the protein universe and resolve disease, today announced the appointment of <person value="APIN:1758666824">Chris Schade</person>, Growth Partner at Flagship Pioneering, as Chairperson of the Board, succeeding <person>Noubar Afeyan</person>, Ph.D., Co-Founder of Alltrna and Founder and CEO of Flagship Pioneering. In addition, Alltrna also announced the appointments http://www.streetinsider.com/Press+Releases/Alltrna+Announces+Updates+to+Its+Board+of+Directors/23472212.html Wed, 17 Jul 2024 08:00:00 -0400 2020 2023 A.01090263 A.13592230 A.27505448 A.27560722 A.27952506 A.35954321 A.40221050 A.40873631 A.50110756 A.50200199 APRE ARQL CYTK EVLO FHTX IART IONS MEDX MRNA NRG O.00016952 O.00095428 O.00134870 O.00170254 O.00170871 O.00174334 O.00644488 O.05654636 O.06732888 O.08438071 O.15696008 O.20042365 O.20737027 O.22555989 O.29788715 O.39449410 O.42040581 O.49002690 O.49824919 O.51354437 OMGA OMTH S1GE34 SANA SGEN SYRS